Seguro FS - Search Results

1

Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response.

Ferreira APS, Seguro FS, Abdo ARN, Santos FM, Maciel FVR, Nardinelli L, Giorgi RR, Ruiz ARL, Ferreira MPS, Rego EM, Rocha V, Bendit I. Ferreira APS, et al. Among authors: seguro fs. Ann Hematol. 2023 Jul;102(7):1761-1771. doi: 10.1007/s00277-023-05189-3. Epub 2023 Apr 13. Ann Hematol. 2023. PMID: 37052662 Free PMC article.

2

Response to dasatinib in a patient with concomitant chronic myeloid leukemia and chronic lymphocytic leukemia.

Serpa M, Bendit I, Seguro F, Xavier F, Cavalcante M, Steinbaum D, Nardinelli L, Aldred VL, de Paula HM, Dorlhiac-Llacer PE. Serpa M, et al. Acta Haematol. 2010;124(2):105-9. doi: 10.1159/000318009. Epub 2010 Aug 19. Acta Haematol. 2010. PMID: 20720403

3

Efficacy and tolerability after unusually low doses of dasatinib in chronic myeloid leukemia patients intolerant to standard-dose dasatinib therapy.

Serpa M, Sanabani SS, Bendit I, Seguro F, Xavier F, Barroso CB, Conchon M, Dorlhiac-Llacer PE. Serpa M, et al. Clin Med Insights Oncol. 2010 Dec 19;4:155-62. doi: 10.4137/CMO.S6413. Clin Med Insights Oncol. 2010. PMID: 21234296 Free PMC article.

4

Dasatinib overrides imatinib resistance mediated by the F359I residue mutation in two patients with chronic myeloid leukemia.

Serpa M, Sanabani SS, Dorlhiac-Llacer PE, Nardinelli L, de Barros Ferreira P, Martins TF, Seguro F, Bendit I. Serpa M, et al. Acta Haematol. 2012;127(1):56-9. doi: 10.1159/000333092. Epub 2011 Nov 17. Acta Haematol. 2012. PMID: 22094354

5

Risk factors and incidence of thrombosis in a Brazilian cohort of patients with Philadelphia-negative myeloproliferative neoplasms.

Seguro FS, Teixeira LLC, da Rosa LI, da Silva WF, Nardinelli L, Bendit I, Rocha V. Seguro FS, et al. J Thromb Thrombolysis. 2020 May;49(4):667-672. doi: 10.1007/s11239-019-02029-y. J Thromb Thrombolysis. 2020. PMID: 31898273

6

Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience.

Silva WFD, Rosa LID, Seguro FS, Silveira DRA, Bendit I, Buccheri V, Velloso EDRP, Rocha V, Rego EM. Silva WFD, et al. Among authors: seguro fs. Clinics (Sao Paulo). 2020 Apr 6;75:e1566. doi: 10.6061/clinics/2020/e1566. eCollection 2020. Clinics (Sao Paulo). 2020. PMID: 32294670 Free PMC article.

7

Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring.

Seguro FS, Silva CMPDC, Moura CMB, Conchon M, Fogliatto L, Funke VAM, Abdo A, Macedo AVS, Santos MHHD, Saraiva JFK. Seguro FS, et al. Hematol Transfus Cell Ther. 2021 Apr-Jun;43(2):191-200. doi: 10.1016/j.htct.2020.04.009. Epub 2020 Jul 1. Hematol Transfus Cell Ther. 2021. PMID: 32631809 Free PMC article. Review.

8

MR 4log and low levels of NK cells are associated with higher molecular relapse after imatinib discontinuation: Results of a prospective trial.

Seguro FS, Maciel FVR, Santos FM, Abdo ANR, Pereira TDM, Nardinelli L, Rocha V, Bendit I. Seguro FS, et al. Leuk Res. 2021 Feb;101:106516. doi: 10.1016/j.leukres.2021.106516. Epub 2021 Jan 21. Leuk Res. 2021. PMID: 33517185 Clinical Trial.

9

COVID-19 in chronic myeloid leukemia patients in Latin America.

Pagnano KB, Peralta EH, Navarro JR, David Salas LDR, Delgado N, Moiraghi B, Toreli ACM, Perobelli LM, Fechio L, Quixada ATS, Funke V, Bendit I, Seguro FS, Pilleux L, Bortolini J, Lourenço ALG, Sapelli J, Nucci FM, Pavlovsky C, Oliveira LDC, Moura MS, Palma LC, Gonçalves NN, Conchon M, Hokama POM, Almeida LL, Zulli R, de Souza CA, Boquimpani CM. Pagnano KB, et al. Among authors: seguro fs. Leuk Lymphoma. 2021 Dec;62(13):3212-3218. doi: 10.1080/10428194.2021.1950709. Epub 2021 Jul 13. Leuk Lymphoma. 2021. PMID: 34254886

10

Impact of pregnancy on the outcomes of childbearing age women with chronic myeloid leukemia.

Santos FM, Ghelfond G, Seguro FS, Abdo ANR, Dalessandro T, Maciel FVR, Bassolli L, Rocha V, Bendit I. Santos FM, et al. Among authors: seguro fs. Am J Hematol. 2022 Feb 1;97(2):E72-E74. doi: 10.1002/ajh.26424. Epub 2021 Nov 30. Am J Hematol. 2022. PMID: 34822180 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page